Cellebrite DI (CLBT) Beginning Cash Balance (2020 - 2025)

Cellebrite DI (CLBT) has reported Beginning Cash Balance for 6 consecutive years, with $281.4 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Beginning Cash Balance rose 106.35% year-over-year to $281.4 million; the TTM figure through Dec 2025 stood at $652.2 million (up 50.7% YoY), while the FY2025 annual figure was $191.7 million, up 1.13% from the prior year.
• Beginning Cash Balance came in at $281.4 million for Q4 2025 at Cellebrite DI, up from $179.2 million in the prior quarter.
• The five-year high for Beginning Cash Balance was $281.4 million in Q4 2025, with the low at $84.6 million in Q4 2022.
• Average Beginning Cash Balance over 5 years is $140.1 million, with a median of $135.1 million recorded in 2021.
• Across the five-year window, Beginning Cash Balance jumped 269.45% in 2021 and plunged 46.51% in 2022, its largest moves.
• Year by year, Beginning Cash Balance stood at $109.9 million in 2021, then fell by 23.04% to $84.6 million in 2022, then surged by 62.08% to $137.1 million in 2023, then fell by 0.52% to $136.3 million in 2024, then surged by 106.35% to $281.4 million in 2025.
• According to Business Quant data, Beginning Cash Balance over the past three periods registered $281.4 million, $179.2 million, and $191.7 million for Q4 2025, Q3 2025, and Q1 2025 respectively.